Li Luo

ORCID: 0000-0003-4169-5526
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Mechanisms and Therapy
  • Phagocytosis and Immune Regulation
  • FOXO transcription factor regulation
  • Cancer Immunotherapy and Biomarkers
  • Mechanisms of cancer metastasis
  • Immune responses and vaccinations
  • Pancreatic and Hepatic Oncology Research
  • Immune cells in cancer
  • Cancer, Hypoxia, and Metabolism
  • Single-cell and spatial transcriptomics
  • Hippo pathway signaling and YAP/TAZ
  • Cytokine Signaling Pathways and Interactions
  • Hematological disorders and diagnostics
  • Autophagy in Disease and Therapy

Sun Yat-sen University
2023-2024

The First Affiliated Hospital, Sun Yat-sen University
2024

Sun Yat-sen University Cancer Center
2023

Metabolic fitness of T cells is essential for their vitality, which largely dependent on the behavior mitochondria. The nature mitochondrial in tumor-infiltrating remains poorly understood. In this study, we show that mitofusin-2 (MFN2) expression positively correlated with prognosis multiple cancers. Genetic ablation Mfn2 CD8+ dampens metabolism and function promotes tumor progression. cells, MFN2 enhances mitochondria-endoplasmic reticulum (ER) contact by interacting ER-embedded...

10.1126/sciimmunol.abq2424 article EN Science Immunology 2023-09-22

Liver metastasis is the leading cause of mortality in patients with colorectal cancer. Given significance both epithelial-mesenchymal transition (EMT) tumor cells and immune microenvironment cancer liver (CRLM), interplay between them could hold key for developing improved treatment options. We employed multiomics analysis 130 samples from 18 synchronous CRLM integrated external datasets to comprehensively evaluate interaction EMT metastasis. Single-cell RNA sequencing revealed distinct...

10.1158/0008-5472.can-23-2123 article EN Cancer Research 2024-02-09

<div>Abstract<p>Liver metastasis is the leading cause of mortality in patients with colorectal cancer. Given significance both epithelial–mesenchymal transition (EMT) tumor cells and immune microenvironment cancer liver (CRLM), interplay between them could hold key for developing improved treatment options. We employed multiomics analysis 130 samples from 18 synchronous CRLM integrated external datasets to comprehensively evaluate interaction EMT metastasis. Single-cell RNA...

10.1158/0008-5472.c.7181314.v1 preprint EN 2024-04-15

<div>Abstract<p>Liver metastasis is the leading cause of mortality in patients with colorectal cancer. Given significance both epithelial–mesenchymal transition (EMT) tumor cells and immune microenvironment cancer liver (CRLM), interplay between them could hold key for developing improved treatment options. We employed multiomics analysis 130 samples from 18 synchronous CRLM integrated external datasets to comprehensively evaluate interaction EMT metastasis. Single-cell RNA...

10.1158/0008-5472.c.7181314 preprint EN 2024-04-15

<div>Abstract<p>Liver metastasis is the leading cause of mortality in patients with colorectal cancer. Given significance both epithelial–mesenchymal transition (EMT) tumor cells and immune microenvironment cancer liver (CRLM), interplay between them could hold key for developing improved treatment options. We employed multiomics analysis 130 samples from 18 synchronous CRLM integrated external datasets to comprehensively evaluate interaction EMT metastasis. Single-cell RNA...

10.1158/0008-5472.c.7181314.v2 preprint EN 2024-04-15
Coming Soon ...